|
Orthologous residues
|
|
tau (human): S713‑p, tau iso2 (human): S307‑p, tau iso3 (human): S271‑p, tau iso5 (human): S365‑p, tau iso6 (human): S338‑p, tau iso8 (human): S396‑p, tau (mouse): S688‑p, tau iso3 (mouse): S385‑p, tau iso7 (mouse): S345‑p, tau (rat): S707‑p, tau (cow): S403‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
brain, CHO (fibroblast)
|
|
Cellular systems studied:
cell lines, tissue
|
|
Species studied:
hamster, human
|
|
Comments:
fetal, postnatal, and adult
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cytoskeletal reorganization
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
TUBB (human)
|
|
Disrupts
|
|
cytoskeletal reorganization
|
co-immunoprecipitation
|
|
|
Associated Diseases
|
|
Diseases:
|
Alterations:
|
Comments:
|
|
Alzheimer's disease
|
hyperphosphorylation
|
|
|